Information regarding the crosstalk between STAT3 and STAT5, specifically in breast cancer, is limited, and further research on this relationship could help with developing new treatment strategies targeting these STATs, particularly in TNBC, where STAT3 is often constitutively active and STAT5 is often inactive. This evidence concerns the gene STAT5A and breast cancer.